242 related articles for article (PubMed ID: 33260723)
1. Evaluation of the Cytotoxicity of Ayahuasca Beverages.
Simão AY; Gonçalves J; Gradillas A; García A; Restolho J; Fernández N; Rodilla JM; Barroso M; Duarte AP; Cristóvão AC; Gallardo E
Molecules; 2020 Nov; 25(23):. PubMed ID: 33260723
[TBL] [Abstract][Full Text] [Related]
2. Gas chromatographic analysis of dimethyltryptamine and beta-carboline alkaloids in ayahuasca, an Amazonian psychoactive plant beverage.
Pires AP; De Oliveira CD; Moura S; Dörr FA; Silva WA; Yonamine M
Phytochem Anal; 2009; 20(2):149-53. PubMed ID: 19140116
[TBL] [Abstract][Full Text] [Related]
3. Mutagenicity of Ayahuasca and Their Constituents to the Salmonella/Microsome Assay.
Kummrow F; Maselli BS; Lanaro R; Costa JL; Umbuzeiro GA; Linardi A
Environ Mol Mutagen; 2019 Apr; 60(3):269-276. PubMed ID: 30488498
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective potential of Ayahuasca and untargeted metabolomics analyses: applicability to Parkinson's disease.
Katchborian-Neto A; Santos WT; Nicácio KJ; Corrêa JOA; Murgu M; Martins TMM; Gomes DA; Goes AM; Soares MG; Dias DF; Chagas-Paula DA; Paula ACC
J Ethnopharmacol; 2020 Jun; 255():112743. PubMed ID: 32171895
[TBL] [Abstract][Full Text] [Related]
5. Ayahuasca: Psychological and Physiologic Effects, Pharmacology and Potential Uses in Addiction and Mental Illness.
Hamill J; Hallak J; Dursun SM; Baker G
Curr Neuropharmacol; 2019; 17(2):108-128. PubMed ID: 29366418
[TBL] [Abstract][Full Text] [Related]
6. Metabolism and disposition of N,N-dimethyltryptamine and harmala alkaloids after oral administration of ayahuasca.
Riba J; McIlhenny EH; Valle M; Bouso JC; Barker SA
Drug Test Anal; 2012; 4(7-8):610-6. PubMed ID: 22514127
[TBL] [Abstract][Full Text] [Related]
7. The globalization of ayahuasca: harm reduction or benefit maximization?
Tupper KW
Int J Drug Policy; 2008 Aug; 19(4):297-303. PubMed ID: 18638702
[TBL] [Abstract][Full Text] [Related]
8. Determination of Tryptamines and β-Carbolines in Ayahuasca Beverage Consumed During Brazilian Religious Ceremonies.
Santos MC; Navickiene S; Gaujac A
J AOAC Int; 2017 May; 100(3):820-824. PubMed ID: 28105971
[TBL] [Abstract][Full Text] [Related]
9. Immunological Modulation and Control of Parasitaemia by Ayahuasca Compounds: Therapeutic Potential for Chagas's Disease.
Katchborian-Neto A; Santos MFC; Vilas-Boas DF; Dos Santos EG; Veloso MP; Bueno PCP; Caldas IS; Soares MG; Dias DF; Chagas-Paula DA
Chem Biodivers; 2022 Oct; 19(10):e202200409. PubMed ID: 36163588
[TBL] [Abstract][Full Text] [Related]
10. Ritualistic Use of Ayahuasca versus Street Use of Similar Substances Seized by the Police: A Key Factor Involved in the Potential for Intoxications and Overdose?
Lanaro R; Calemi DB; Togni LR; Costa JL; Yonamine M; Cazenave Sde O; Linardi A
J Psychoactive Drugs; 2015; 47(2):132-9. PubMed ID: 25950593
[TBL] [Abstract][Full Text] [Related]
11. Effects of the South American psychoactive beverage ayahuasca on regional brain electrical activity in humans: a functional neuroimaging study using low-resolution electromagnetic tomography.
Riba J; Anderer P; Jané F; Saletu B; Barbanoj MJ
Neuropsychobiology; 2004; 50(1):89-101. PubMed ID: 15179026
[TBL] [Abstract][Full Text] [Related]
12. Chemical Composition of Traditional and Analog Ayahuasca.
Kaasik H; Souza RCZ; Zandonadi FS; Tófoli LF; Sussulini A
J Psychoactive Drugs; 2021; 53(1):65-75. PubMed ID: 32896230
[TBL] [Abstract][Full Text] [Related]
13. Identification of N,N-dimethyltryptamine and beta-carbolines in psychotropic ayahuasca beverage.
Gambelunghe C; Aroni K; Rossi R; Moretti L; Bacci M
Biomed Chromatogr; 2008 Oct; 22(10):1056-9. PubMed ID: 18506697
[TBL] [Abstract][Full Text] [Related]
14. Kinetic profile of N,N-dimethyltryptamine and β-carbolines in saliva and serum after oral administration of ayahuasca in a religious context.
Lanaro R; Mello SM; da Cunha KF; Silveira G; Corrêa-Neto NF; Hyslop S; Cabrices OG; Costa JL; Linardi A
Drug Test Anal; 2021 Mar; 13(3):664-678. PubMed ID: 33119972
[TBL] [Abstract][Full Text] [Related]
15. In Vitro Study of the Bioavailability and Bioaccessibility of the Main Compounds Present in Ayahuasca Beverages.
Gonçalves J; Castilho M; Rosado T; Luís Â; Restolho J; Fernández N; Gallardo E; Duarte AP
Molecules; 2021 Sep; 26(18):. PubMed ID: 34577025
[TBL] [Abstract][Full Text] [Related]
16. Ayahuasca: Pharmacology, neuroscience and therapeutic potential.
Domínguez-Clavé E; Soler J; Elices M; Pascual JC; Álvarez E; de la Fuente Revenga M; Friedlander P; Feilding A; Riba J
Brain Res Bull; 2016 Sep; 126(Pt 1):89-101. PubMed ID: 26976063
[TBL] [Abstract][Full Text] [Related]
17. Analytical techniques for the determination of tryptamines and β-carbolines in plant matrices and in psychoactive beverages consumed during religious ceremonies and neo-shamanic urban practices.
Gaujac A; Navickiene S; Collins MI; Brandt SD; de Andrade JB
Drug Test Anal; 2012; 4(7-8):636-48. PubMed ID: 22577086
[TBL] [Abstract][Full Text] [Related]
18. Topographic pharmaco-EEG mapping of the effects of the South American psychoactive beverage ayahuasca in healthy volunteers.
Riba J; Anderer P; Morte A; Urbano G; Jané F; Saletu B; Barbanoj MJ
Br J Clin Pharmacol; 2002 Jun; 53(6):613-28. PubMed ID: 12047486
[TBL] [Abstract][Full Text] [Related]
19. Effect of Ritualistic Consumption of Ayahuasca on Hepatic Function in Chronic Users.
Mello SM; Soubhia PC; Silveira G; Corrêa-Neto NF; Lanaro R; Costa JL; Linardi A
J Psychoactive Drugs; 2019; 51(1):3-11. PubMed ID: 30582439
[TBL] [Abstract][Full Text] [Related]
20. Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat.
Pic-Taylor A; da Motta LG; de Morais JA; Junior WM; Santos Ade F; Campos LA; Mortari MR; von Zuben MV; Caldas ED
Behav Processes; 2015 Sep; 118():102-10. PubMed ID: 26049017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]